Bientinesi, Riccardo
 Distribuzione geografica
Continente #
EU - Europa 3.380
NA - Nord America 2.284
AS - Asia 1.594
SA - Sud America 336
AF - Africa 58
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.662
Nazione #
US - Stati Uniti d'America 2.193
IT - Italia 1.791
SG - Singapore 751
DE - Germania 416
CN - Cina 379
SE - Svezia 321
BR - Brasile 279
FR - Francia 204
UA - Ucraina 180
GB - Regno Unito 110
IN - India 99
IE - Irlanda 79
NL - Olanda 66
ID - Indonesia 59
VN - Vietnam 57
JP - Giappone 49
RU - Federazione Russa 46
CA - Canada 42
FI - Finlandia 41
HK - Hong Kong 31
BD - Bangladesh 27
MX - Messico 27
PL - Polonia 26
AR - Argentina 25
BE - Belgio 25
KR - Corea 25
ES - Italia 21
TR - Turchia 19
ZA - Sudafrica 19
IQ - Iraq 16
CH - Svizzera 13
EC - Ecuador 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
EG - Egitto 9
IR - Iran 9
PK - Pakistan 9
MA - Marocco 7
VE - Venezuela 7
HU - Ungheria 6
AU - Australia 5
MY - Malesia 5
PE - Perù 5
UZ - Uzbekistan 5
CL - Cile 4
CZ - Repubblica Ceca 4
HN - Honduras 4
LK - Sri Lanka 4
LT - Lituania 4
NP - Nepal 4
PH - Filippine 4
CR - Costa Rica 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BZ - Belize 2
CO - Colombia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
MM - Myanmar 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
Totale 7.659
Città #
Chandler 365
Singapore 358
Rome 289
Ashburn 261
Milan 168
Ann Arbor 97
Beijing 87
Los Angeles 82
Jacksonville 80
Dublin 78
New York 74
San Mateo 64
Jakarta 55
Wilmington 47
Florence 45
Hefei 45
The Dalles 44
Nanjing 37
Munich 36
Naples 35
São Paulo 31
Hong Kong 30
Frankfurt am Main 28
Kadoma 28
Houston 25
Nanchang 25
Woodbridge 25
Bari 24
Dearborn 24
Moscow 24
Boston 23
Hyderabad 23
Seattle 22
Bremen 21
Brussels 21
Cattolica 21
Lawrence 21
Bologna 20
Dallas 19
Ho Chi Minh City 19
Redwood City 18
Verona 18
Buffalo 17
Seoul 17
Stockholm 17
Toronto 17
Denver 16
Hanoi 16
Marseille 16
Turin 16
Chicago 15
Düsseldorf 15
Johannesburg 15
Mountain View 15
Palermo 15
Princeton 15
Fairfield 14
Catania 13
Kent 13
Lancaster 13
London 13
Warsaw 13
Nürnberg 12
Redmond 12
Tokyo 12
Atlanta 11
Cagliari 11
Chennai 11
Montreal 11
San Francisco 11
Washington 11
Poplar 10
Sesto Fiorentino 10
Abidjan 9
Baku 9
Boardman 9
Menlo Park 9
Padova 9
Saint Petersburg 9
Genoa 8
Lauterbourg 8
Orem 8
Rio de Janeiro 8
Amsterdam 7
Augusta 7
Baghdad 7
Belo Horizonte 7
Bexley 7
Brooklyn 7
Helsinki 7
Kunming 7
Macerata 7
Ottawa 7
Paris 7
Phoenix 7
Roubaix 7
Santa Clara 7
Taranto 7
Tianjin 7
Bedizzole 6
Totale 3.484
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.184
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 905
Le infezioni delle vie urinarie 223
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 177
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 172
The occult urothelial cancer 171
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 161
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 156
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 152
[Overactive bladder syndrome: the social and economic perspective] 149
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 149
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 149
Bladder and prostate metastasis from small cell lung cancer: a rare entity 148
Antibiotic prophylaxis in urology 146
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 146
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 135
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 133
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 127
The occult urothelial cancer 118
Current status of robotic urologic surgery in Italy 116
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 111
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 110
Double J stent migration in the contralateral ureter during robotassisted pyeloplasty: an unique complication 108
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 105
Methylation study of the Paris system for reporting urinary (TPS) categories 105
Retigabine induces relaxations of the human bladder detrusor 101
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 99
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 99
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 98
Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review 98
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 95
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 93
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 90
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 88
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 85
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 85
Lifestyle in urology: Cancer 85
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 83
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 83
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 78
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 77
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 77
What can the metaverse do for urology? 75
Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature 74
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 72
Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences 71
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 70
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 70
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 69
Managing urinary incontinence in women - a review of new and emerging pharmacotherapy 67
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 65
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 62
Managing urological disorders in multiple sclerosis patients: A review of available and emerging therapies 61
Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline? 56
Mirabegron: A review of recent data and its prospects in the management of overactive bladder 54
Totale 7.736
Categoria #
all - tutte 28.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 32 40 23 53 30 75 20
2021/2022545 52 27 30 52 45 32 17 60 41 40 57 92
2022/20231.109 132 138 90 177 71 120 60 101 125 21 39 35
2023/20241.145 66 147 79 102 67 90 76 129 68 96 86 139
2024/20251.606 71 67 124 65 140 91 98 74 205 179 271 221
2025/20261.673 389 101 158 338 561 126 0 0 0 0 0 0
Totale 7.736